Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2491 to 2505 of 9088 results

  1. Subcutaneous ocrelizumab for treating primary progressive or relapsing multiple sclerosis [TSID11895]

    Topic prioritisation

  2. Sumatriptan–naproxen for treating migraine-related moderate to severe headache [TS ID 12055]

    Topic prioritisation

  3. Eptinezumab for preventing cluster headache attacks TSID 12087

    Topic prioritisation

  4. Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106

    Topic prioritisation

  5. Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]

    Topic prioritisation

  6. Dapsone for treating COVID-19 in people 40 years and over with high-risk comorbidity and people 70 years and over [TSID11892]

    Topic prioritisation

  7. Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]

    Topic prioritisation

  8. Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]

    Topic prioritisation

  9. Healthy.io test for home testing of urine albumin to creatinine ratio

    Topic prioritisation

  10. LIVERFASt for diagnosing and staging liver injury and chronic liver disease, (MT783)

    Topic prioritisation

  11. Extracorporeal bioartificial liver assist therapy

    Topic prioritisation

  12. Percutaneous nephrolithotomy for kidney stones greater than 1.5cm

    Topic prioritisation

  13. RenalSense Clarity RMS for acute kidney injury MT601 (MIB256)

    Topic prioritisation